United States set
language
Menu Shopping cart $0 Search

References to miR-197-3p

  • Zampetaki, Anna, et al. "Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes." Circulation research 107.6 (2010): 810-817.
  • Zampetaki, Anna, et al. "Prospective study on circulating MicroRNAs and risk of myocardial infarction." Journal of the American College of Cardiology 60.4 (2012): 290-299.
  • Karolina, Dwi Setyowati, et al. "Circulating miRNA profiles in patients with metabolic syndrome." The Journal of Clinical Endocrinology & Metabolism 97.12 (2012): E2271-E2276.
  • Jernås, Margareta, et al. "MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)." BMC immunology 14.1 (2013): 32.
  • Choi, S-Y., et al. "MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray." Placenta34.9 (2013): 799-804.
  • Chen, Li, et al. "miR-197 expression in peripheral blood mononuclear cells from hepatitis B virus-infected patients." Gut and liver 7.3 (2013): 335.
  • Abd-El-Fattah, Amal A., et al. "Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia." Cell biochemistry and biophysics67.3 (2013): 875-884.
  • Fiori, M. E., et al. "Antitumor effect of miR-197 targeting in p53 wild-type lung cancer." Cell death and differentiation 21.5 (2014): 774.
  • Dai, Weiqi, et al. "Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82." Biochemical and biophysical research communications 446.2 (2014): 541-548.
  • Hamada, Shin, et al. "miR‐197 induces epithelial–mesenchymal transition in pancreatic cancer cells by targeting p120 catenin." Journal of cellular physiology 228.6 (2013): 1255-1263.
  • Nikiforova, Marina N., et al. "MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility." The Journal of Clinical Endocrinology & Metabolism 93.5 (2008): 1600-1608.
  • Hu, Qiyan, et al. "miR 197 is downregulated in cervical carcinogenesis and suppresses cell proliferation and invasion through targeting forkhead box M1." Oncology letters 15.6 (2018): 10063-10069.
  • Mavridis, K., et al. "The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients." British journal of cancer 112.9 (2015): 1527.
  • Yang, Jeong Mi, et al. "Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma." Journal of translational medicine 16.1 (2018): 162.
  • Liao, Zhiwei, et al. "MicroRNA-197 inhibits gastric cancer progression by directly targeting metadherin." Molecular medicine reports 17.1 (2018): 602-611.